You are here

antipsychotic

After FDA approval, Alkermes plans soft launch for antipsychotic Lybalvi

Pharmaforum

Thu, 06/3/21 - 10:37 am

AstraZeneca to sell anti-psychotic medicine rights in Europe and Russia for $239m

Pharmaceutical Business Review

Thu, 10/31/19 - 10:14 am

Acadia can’t shake off its Nuplazid nightmare

EP Vantage

Tue, 07/10/18 - 04:59 pm

Commonly used drug can cause uncontrollable urge to gamble and have sex, FDA says

Stat

Tue, 05/3/16 - 09:53 pm

Bristol-Myers Squibb

Allergan and Richter win FDA approval for a once-rejected schizophrenia pill

Fierce Biotech

Thu, 09/17/15 - 05:21 pm

bipolar disorder

FDA warns Pfizer antipsychotic linked to serious allergic reaction

In-Pharma Technologist

Tue, 12/16/14 - 11:47 pm

Alexza Poised For Run-Up Into December U.S., EU Approval Decisions

Seeking Alpha

Thu, 09/6/12 - 10:17 am